Intestin des connectivites et vascularites

Khanna, 2009, Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument, Arthritis Rheum, 61, 1257, 10.1002/art.24730 Sjogren, 1994, Gastrointestinal motility disorders in scleroderma, Arthritis Rheum, 37, 1265, 10.1002/art.1780370902 Cohen, 1972, The pathogenesis of esophageal dysfunction in scleroderma and Raynaud's disease, J Clin Invest, 51, 2663, 10.1172/JCI107084 Marie, 2006, Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy, Aliment Pharmacol Ther, 24, 1593, 10.1111/j.1365-2036.2006.03180.x Howe, 1994, Antimyenteric neuronal antibodies in scleroderma, J Clin Invest, 94, 761, 10.1172/JCI117395 Kawaguchi, 2009, Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility, Ann Rheum Dis, 68, 710, 10.1136/ard.2008.096545 Roberts, 2006, A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma), Gut, 55, 1697, 10.1136/gut.2005.086074 Abu-Shakra, 1994, Gastrointestinal manifestations of systemic sclerosis, Semin Arthritis Rheum, 24, 29, 10.1016/0049-0172(94)90097-3 Lock, 1997, Gastrointestinal manifestations of progressive systemic sclerosis, Am J Gastroenterol, 92, 763 Marie, 2006, Gastrointestinal involvement in systemic sclerosis, Presse Med, 35, 1952, 10.1016/S0755-4982(06)74930-2 Sjogren, 1996, Gastrointestinal features of scleroderma, Curr Opin Rheumatol, 8, 569, 10.1097/00002281-199611000-00012 Bures, 2010, Small intestinal bacterial overgrowth syndrome, World J Gastroenterol, 16, 2978, 10.3748/wjg.v16.i24.2978 Parodi, 2008, Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication, Am J Gastroenterol, 103, 1257, 10.1111/j.1572-0241.2007.01758.x Tauber, 2014, Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms, Clin Exp Rheumatol, 32, S62 Perlemuter, 2001, Chronic intestinal pseudo-obstruction secondary to connective tissue diseases, Gastroenterol Clin Biol, 25, 251 Viallard, 1998, Exudative enteropathy in disseminated lupus erythematosus. Report of 3 cases and review of the literature, Ann Med Interne, 149, 485 Rensch, 2001, The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus, Am J Gastroenterol, 96, 1113, 10.1111/j.1572-0241.2001.03753.x Roblin, 2004, Celiac disease must be evaluated in patients with Sjogren syndrome, Arch Intern Med, 164, 2387, 10.1001/archinte.164.21.2387-b Jean, 1999, Lymphocytic colitis and Gougerot-Sjogren syndrome. Report of two cases, Rev Med Interne, 20, 923, 10.1016/S0248-8663(00)80098-3 Sheikh, 1995, The gastrointestinal manifestations of Sjogren's syndrome, Am J Gastroenterol, 90, 9 Pagnoux, 2003, Abdominal and digestive manifestations in systemic vasculitides, Ann Med Interne, 154, 457 Storesund, 1998, Severe intestinal involvement in Wegener's granulomatosis: report of two cases and review of the literature, Br J Rheumatol, 37, 387, 10.1093/rheumatology/37.4.387 Kram, 2003, Behcet's ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case, Dis Colon Rectum, 46, 118, 10.1007/s10350-004-6506-4